If your sugar isnt high, it doesnt force insulin production
17.1% on 4mg (NEJM, Jastreboff 2023) No plateau: Weight was still declining at 48 weeks in Phase 2 and continued through 68 weeks in Phase 3 Body composition: 74% of weight lost was fat mass, 26% lean mass, based on DEXA scan data from Phase 2 Realistic range: Most people starting retatrutide should expect 1525% weight loss over 1218 months at therapeutic doses, assuming reasonable adherence and lifestyle changes Not FDA-approved: Currently investigational
By sourcing BPC-157 from suppliers that emphasize over 99% purity, robust testing, and transparent labeling, investigators can trust that their results genuinely reflect the peptide they intended to study
Ashley Koff, RD 00:32:06 So a couple of thoughts here
Some prescribers recommend split-dose protocols
Please Enable the JavaScript to continue